Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: We will evaluate the efficacy and safety of favipiravir and interferon beta-1a compared to lopinavir/ritonavir and interferon beta-1a in patients with confirmed COVID-19, who are moderately ill. TRIAL DESIGN: This is a phase 3, single-center, randomized, open-label, controlled trial with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassaniazad, Mehdi, Bazram, Ali, Hassanipour, Soheil, Fathalipour, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588588/
https://www.ncbi.nlm.nih.gov/pubmed/33109246
http://dx.doi.org/10.1186/s13063-020-04747-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588588/
https://www.ncbi.nlm.nih.gov/pubmed/33109246
http://dx.doi.org/10.1186/s13063-020-04747-8

Ejemplares similares